OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identifying FAAH Inhibitors as New Therapeutic Options for the Treatment of Chronic Pain through Drug Repurposing
Anca Zanfirescu, Georgiana Nițulescu, Dragoș Paul Mihai, et al.
Pharmaceuticals (2021) Vol. 15, Iss. 1, pp. 38-38
Open Access | Times Cited: 20

Showing 20 citing articles:

The Polyphenolic Profile and Antioxidant Activity of Five Vegetal Extracts with Hepatoprotective Potential
Liliana Costea, Carmen Lidia Chițescu, Rica Boscencu, et al.
Plants (2022) Vol. 11, Iss. 13, pp. 1680-1680
Open Access | Times Cited: 29

The Skin and Natural Cannabinoids–Topical and Transdermal Applications
Silviu-Iulian Filipiuc, Anca-Narcisa Neagu, Cristina Mariana Urîtu, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1049-1049
Open Access | Times Cited: 18

Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy
MariaLuisa Vigano, Lixing Wang, Alia As’sadiq, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Phytochemical Screening and Antioxidant Potential of Selected Extracts from Betula alba var. pendula Roth., Glycyrrhiza glabra L., and Avena sativa L.
Adelina Ghica, Veronica Drumea, Alina Moroșan, et al.
Plants (2023) Vol. 12, Iss. 13, pp. 2510-2510
Open Access | Times Cited: 10

Repositioning of tubocurarine as analgesic and anti-inflammatory agent: Exploring beyond myorelaxant activity
Saraswati Patel, Jyoti Shukla, Smita Jain, et al.
Biochemical Pharmacology (2022) Vol. 205, pp. 115248-115248
Closed Access | Times Cited: 14

Natural Active Ingredients and TRPV1 Modulation: Focus on Key Chemical Moieties Involved in Ligand–Target Interaction
Corina Andrei, Anca Zanfirescu, George Mihai Niţulescu, et al.
Plants (2023) Vol. 12, Iss. 2, pp. 339-339
Open Access | Times Cited: 7

Comparative Transcriptome of Dorsal Root Ganglia Reveals Distinct Etiologies of Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy in Rats
Wuping Sun, Yue Hao, Rongzhen Li, et al.
Neuroscience (2023) Vol. 516, pp. 1-14
Closed Access | Times Cited: 7

Cytotoxicity Analysis and In Silico Studies of Three Plant Extracts with Potential Application in Treatment of Endothelial Dysfunction
Andreea Roxana Ungureanu, Violeta Popovici, Camelia Oprean, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2125-2125
Open Access | Times Cited: 7

Evaluating the Impact of Probiotic Therapy on the Endocannabinoid System, Pain, Sleep and Fatigue: A Randomized, Double-Blind, Placebo-Controlled Trial in Dancers
Jakub Wiącek, Tomasz Podgórski, Krzysztof Kusy, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5611-5611
Open Access | Times Cited: 2

In Silico and In Vitro Studies on an Asymmetrical Porphyrin Derivative with Therapeutic Potential in Skin Disorders
Andreea Mihaela Burloiu, Dragoș Paul Mihai, Gina Manda, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 688-688
Open Access | Times Cited: 2

Cannabinoids—Multifunctional Compounds, Applications and Challenges—Mini Review
Dominik Duczmal, Aleksandra Bazan-Woźniak, Krystyna Niedzielska, et al.
Molecules (2024) Vol. 29, Iss. 20, pp. 4923-4923
Open Access | Times Cited: 2

In Silico Drug Repurposing Framework Predicts Repaglinide, Agomelatine and Protokylol as TRPV1 Modulators with Analgesic Activity
Corina Andrei, Dragoș Paul Mihai, Anca Zanfirescu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2563-2563
Open Access | Times Cited: 8

Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs
Hong-Qing Zhao, Yang Liu, Na Cai, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2143-2167
Open Access | Times Cited: 1

Montelukast as a potential treatment for COVID-19
Matthew W. McCarthy
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 5, pp. 551-555
Closed Access | Times Cited: 3

An Overview on Computational Methods Targeting the Endocannabinoid System
Gabriel Marques, Pedro Augusto Lemos Santana, Renata Barbosa de Oliveira
(2024), pp. 503-523
Closed Access

Anandamide: The good and bad in epilepsy
Renaud C. Gom, Pasindu Wickramarachchi, Roberto Colangeli, et al.
Elsevier eBooks (2024), pp. 399-418
Closed Access

Cetirizine and Levetiracetam as Inhibitors of Monoacylglycerol Lipase: Investigating Their Repurposing Potential as Novel Osteoarthritic Pain Therapies
Corina Andrei, Dragoș Paul Mihai, Georgiana Nițulescu, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1563-1563
Open Access | Times Cited: 1

Structural Model Based on Genetic Algorithm for Inhibiting Fatty Acid Amide Hydrolase
Cosmin Trif, Dragoș Paul Mihai, Anca Zanfirescu, et al.
AI (2022) Vol. 3, Iss. 4, pp. 863-870
Open Access | Times Cited: 1

Page 1

Scroll to top